DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
DiaMedica Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 4, 2023
DiaMedica Therapeutics reported fiscal year 2022 executive compensation information on April 4, 2023.
In 2022, three executives at DiaMedica Therapeutics received on average a compensation package of $883K, a 19% increase compared to previous year.
Average pay of disclosed executives at DiaMedica Therapeutics
Rick Pauls, Chief Executive Officer, received $1.1M in total, which decreased by 5% compared to 2021. 48% of Pauls' compensation, or $523K, was in salary. Pauls also received $198K in non-equity incentive plan, $344K in option awards, as well as $16K in other compensation.
Kirsten Gruis, Chief Medical Officer, received a compensation package of $1M. 49% of the compensation package, or $488K, was in option awards.
Scott Kellen, Chief Financial Officer, earned $564K in 2022, a 3% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 4, 2023.